/Investor DB

Red Tree Venture — 2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

ViaCyteviacyte.comNov 2018SEC filingmedium confidence

Transforming the lives of patients through a functional cure for Type 1 Diabetes

BiotechSan Diego, US

Brittany Bradrick(Executive Officer)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Steve White(Executive Officer)Howard Foyt(Executive Officer)inKevin D'Amour(Executive Officer)in

Board seatHeath Lukatch· per SEC Form D · $90M raise · filed Dec 2018

Co-investorsArtis VenturesATEL VenturesBain Capital Life SciencesRA CapitalSanderling VenturesThe Vertical Group+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ViewPoint Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.